Related by context. All words. (Click for frequent words.) 74 peptidic compound 74 XL# anticancer compounds 74 accumulate preferentially 73 developing Bicifadine serotonin 72 Alfacell proprietary ribonuclease 72 candidate deforolimus 72 targeted antifolate 72 liposomal formulation 72 Pruvel TM 71 taxane derivative 71 triggers apoptosis programmed 71 var arrContent = 71 LymphoStat B belimumab 71 IMiDs R 71 IMiDs ® 71 rHuPH# recombinant human 71 signal transduction inhibitor 71 var arrUrl = 71 var arrMeta = 71 pralatrexate injection folate analogue 70 oral Janus kinase 70 humanized therapeutic 70 promotes MERREM ® 70 metaglidasen 70 Locked Nucleic Acid 70 pipeline ImmunoGen collaborators 70 SPL# Gel vaginal microbicide 70 oral dihydropyrimidine dehydrogenase DPD 70 highly selective inhibitor 70 auristatin E MMAE 70 ADP receptor antagonist 70 nucleoside analog 70 agonistic human 70 Initiates Phase II 70 novel synthetic PEGylated 70 multi kinase inhibitor 70 AAG geldanamycin analog 70 CD4 monoclonal antibody 70 CK # skeletal muscle 70 RAS MAPK pathway 69 VEGFR2 inhibitor 69 Atripla combines 69 oral immunomodulatory 69 anionic backbone 69 CYT# potent vascular disrupting 69 Crofelemer budesonide foam 69 Aflibercept VEGF Trap 69 investigational humanized monoclonal antibody 69 PI3K/Akt pathway inhibitor 69 targeted radiotherapeutic 69 HuMax TAC 69 ADCC enhanced 69 IAP inhibitor 69 mertansine 69 non nucleoside inhibitor 69 attach auristatin 69 TRACON Pharmaceuticals 69 Initiates Enrollment 69 Locked Nucleic Acid LNA 69 oral nucleoside analogue 69 TRIOLEX HE# APOPTONE HE# 69 sodium glucose cotransporter 69 5 lipoxygenase activating 69 continuous erythropoietin receptor 69 investigational oral inhibitor 69 Aurora kinase 69 rusalatide acetate 69 GRNOPC1 contains 69 Pruvel ™ 69 vapreotide acetate 69 Archexin 69 AKT inhibitor 69 delivery polymer matrix 69 CYP#A# CYP#D# 69 novel topoisomerase 69 targeted anticancer biopharmaceuticals 68 peptibody 68 developing Zerenex ferric 68 humanized monoclonal antibody 68 adenosine A2A 68 Namenda Memantine HCl 68 PDE4 inhibitor 68 receptor tyrosine kinase inhibitor 68 topical gel formulation 68 folate analogue metabolic 68 product platforms AZX# 68 chimeric monoclonal antibody 68 Pharma Merck Serono 68 SAR# [002] 68 GSK '# 68 P#X# antagonist 68 pan histone deacetylase 68 evaluating picoplatin 68 delivers fluocinolone acetonide FA 68 cytidine nucleoside analog 68 development peramivir neuraminidase 68 PNP inhibitor 68 Romidepsin 68 c Raf kinase 68 Enhanze TM Technology 68 generation nucleoside analog 68 proven DuraSite ® 68 oxidative stress inducer 68 5 HT4 68 LymphoStat B TM 68 ATRA IV 68 alpha folate receptor 68 cyclin dependent kinase CDK 68 kidney urologic 68 MTP inhibitor 68 protein tyrosine phosphatase 1B 68 immunotherapeutic agent 68 MSCRAMM ® 68 Sapacitabine 68 proprietary BiTE ® 68 ImmunoGen TAP technology 68 GVAX ® 68 brand ciclesonide HFA 68 Genentech sanofi aventis 68 non peptidic protease 68 Files IND 68 Completes Patient Enrollment 68 sodium glucose transporter 68 Inc. www.micromet inc.com 68 developing TB4 68 Talabostat 68 hormone LHRH antagonist 68 XL# XL# XL# XL# 68 vinorelbine tartrate 68 IV meropenem 68 targeting CD# 68 liposomal delivery 68 DG# compounds targeting 68 vinca alkaloid 68 non porcine pancreatic 68 CCR9 antagonist 68 Lenocta TM sodium stibogluconate 67 sulfonylhydrazine class 67 PEGylated Fab fragment 67 Vitamin D analogue 67 SUTENT ® 67 Locteron combines 67 5 HT2A inverse 67 erlotinib Tarceva R 67 POTELLIGENT ® 67 XL# XL# 67 orally administered inhibitor 67 small molecule Hedgehog 67 intranasal formulation 67 small molecule thrombopoietin 67 POTELLIGENT R 67 hypoxia selective 67 lipoglycopeptide 67 potent topoisomerase II 67 TELINTRA R 67 polymerase inhibitor 67 OncoVex 67 HCV RNA polymerase 67 Horizant ™ 67 humanized monoclonal 67 humanized anti 67 cortisol synthesis 67 candidates Azedra TM 67 R MSCRAMM 67 selective orally bioavailable 67 Epothilone D 67 platinum chemotherapeutic 67 Panzem NCD 67 Blinatumomab 67 targets HGF FGFR 67 enhanced skin permeation 67 TLR7 agonist 67 Merck OSI Pharmaceuticals 67 small molecule chemotherapeutic 67 optical biosensors 67 potently inhibit 67 TRANSDUR ® 67 cosmetic cosmeceutical products 67 HGS ETR1 mapatumumab 67 generation purine nucleoside 67 inhibitor PPI 67 proteasome inhibitor 67 oral ferric iron 67 TRIOLEX ™ 67 MEK inhibitor 67 CysDisplay R 67 targets Galectin receptors 67 Maribavir 67 acetonide FA 67 telomerase therapeutic 67 mitogen activated ERK kinase 67 mitotic kinesin 67 LX# LX# 67 vascular disrupting agent 67 2 methoxyestradiol 67 flu mAb 67 drug pipeline TAFA# 67 IMiDs ® compound 67 selective kinase inhibitor 67 antiinfectives called 67 Receives Orphan Drug Designation 67 MT#/MEDI-# 67 oncolytic virus therapies 67 highly selective endothelin 67 Hsp# Inhibitor 67 RTP #i 67 PEGylated interferon 67 Captisol ® 67 Veronate R 67 HCV NS5B polymerase 67 Janus Kinase 67 directed radiotherapeutic antibody 67 hypereosinophilic syndrome 67 secretory phospholipase A2 67 Presents Preclinical Data 67 novel peptide 67 treat male hypogonadism 67 oral prodrug 67 IG HCR ;) CO 67 mRNA antagonist 67 apoptosis proteins 67 Omacetaxine 67 HSP# inhibitor 67 virus HCV protease inhibitor 67 5 HT2A serotonin 67 pan HDAC inhibitor 67 Panzem R 66 BiTE R 66 Bucindolol 66 NS5b 66 delta opioid receptor 66 IMPDH inhibitor 66 Please visit www.antisoma.com 66 Nanobody R 66 skeletal sarcomere activators 66 cathepsin K inhibitor 66 lintuzumab SGN 66 recurrent metastatic ovarian cancer 66 Aurora Kinase 66 Oral Suspension USP 66 inflammatory PDE 66 Presents Preclinical 66 Janus kinase 66 Fc fusion protein 66 product candidate Lpathomab 66 plus prednisone prednisolone 66 Mg Usa 66 investigational integrase inhibitor 66 Telik logo TELINTRA 66 histone deacetylase HDAC inhibitor 66 Sphingomab TM 66 oral proteasome inhibitor 66 Vitrasert R 66 novel synthetic peptide 66 oral ghrelin agonist 66 Panzem R NCD 66 systemic lupus erythematosus rheumatoid 66 Provectus Pharmaceuticals specializes 66 molecular chaperone regulation 66 Novel Oral 66 Annamycin 66 defensin mimetic antibiotic 66 R sorafenib tablets 66 introduced NEUGENE 66 Exherin 66 HCV polymerase 66 M# rationally 66 NuMimetic TM 66 dasatinib Sprycel ® 66 TAFA# 66 THR beta agonist 66 rxRNA 66 sapacitabine CYC# 66 agents Tabun Sarin 66 YONDELIS 66 polysaccharide polymer 66 Zorbtive TM 66 selective androgen receptor modulator 66 CYT# vascular disrupting 66 anticancer therapeutics 66 BiTE ® 66 mTOR inhibitor 66 ENMD # 66 Tumour Vascular Disrupting Agent 66 investigational monoclonal antibody 66 reversible inhibitor 66 MKC# MT 66 ALS #-# 66 either acutely decompensated 66 PRN FDA Approves 66 progressive metastatic prostate 66 specific CCR9 antagonist 66 Exelixis compounds 66 humanized antibody 66 dimebon latrepirdine 66 MEK inhibitors 66 Nanobody 66 refractory chronic lymphocytic 66 Achieves Primary Endpoint 66 targeting miR 66 system vaporizes unformulated 66 somatostatin analogue 66 Fleximer R 66 epothilone 66 novel immunomodulatory 66 Initiates Clinical Trial 66 gets USFDA nod 66 Aradigm Logo 66 Survivin antagonist 66 JAK inhibitor 66 antisense inhibitors 66 5 HT3 antagonist 66 based pretargeting methods 66 PORxin TM 66 Meets Primary Endpoint 66 SIX RO ROG 66 Kosan dependence 66 therapeutic monoclonal antibody 66 Xanafide 66 peripherally acting 66 reversible inhibitors 66 Angiocept 66 methylnaltrexone bromide 66 BCG refractory carcinoma 66 Chrysalin r rusalatide acetate 66 Tibotec Therapeutics division 66 Naglazyme R 66 MKC# 66 BCR ABL inhibitors 66 Initiates Dosing 66 Albuferon TM 66 MAGE A3 ASCI 66 aurora kinase 66 hypoxia activated prodrug 66 novel histone deacetylase 66 Therapeutic Competitors Companies 66 topically applied SEPA 66 FOLOTYN ® 66 brivanib 65 Aeolus Pharmaceuticals Announces 65 * olmesartan medoxomil 65 CYP#A# isoenzyme 65 HepeX B TM 65 molecular imaging radiopharmaceutical 65 tumor activated prodrug 65 Epidermal Growth Factor Receptor 65 Investigational Oral 65 hepatoprotective agent 65 cyclin dependent kinase inhibitor 65 selective immunoproteasome inhibitor 65 MT# MEDI 65 Tyrima 65 Crucell PER.C6 65 Xcellerex FlexFactory 65 Crucell PER.C6 ® 65 histone deacetylase HDAC inhibitors 65 Antibody Drug Conjugate 65 dipeptidyl peptidase IV 65 automated radiopharmaceutical distribution 65 siRNA binds 65 humanised antibody 65 mda 7 65 using VIAdel TM 65 including eniluracil ADH 65 Empatic ™ 65 selective A2A adenosine receptor 65 Vytorin combines 65 selectively inhibits 65 epothilones 65 Presents Positive 65 label Lipofen R 65 TKB# 65 Kinase Inhibitor 65 NS5B polymerase 65 recombinant biopharmaceutical 65 Romiplostim 65 AtuRNAi 65 novel emulsion formulation 65 docetaxel Taxotere R 65 Dacetuzumab 65 Budesonide foam crofelemer 65 oral Factor Xa 65 PEGylated docetaxel 65 peripherally restricted 65 mRNA antagonists 65 erlotinib Tarceva ® 65 Factor Receptor 65 nilotinib Tasigna ® 65 Septin9 biomarker 65 Daclizumab 65 Announces Tentative Approval 65 Delta opioid receptor 65 CU NP 65 GPR# agonist 65 6 sulfatase 65 includes Dideco CarboMedics 65 protein kinase inhibitor 65 By JAMAAL ABDUL 65 iobenguane 65 bucindolol hydrochloride 65 Additionally Soligenix 65 anti CD3 monoclonal 65 Initiates Clinical 65 tumor vascular disrupting 65 HuCNS SC ® 65 developing adecatumumab 65 non nucleoside HCV 65 KSP inhibitor 65 Aflibercept 65 Orally administered 65 small molecule tyrosine 65 RONDEL TM 65 Ganciclovir 65 targeted immunotherapies 65 Silodosin 65 certain protein tyrosine 65 Pathway Inhibitor 65 developing Zerenex TM 65 Ridaforolimus 65 4SC AG ISIN DE# 65 Pazopanib 65 Epothilones 65 oral isoform selective HDAC 65 mild vasodilator 65 Serostim ® 65 Epratuzumab 65 PI3K inhibitor 65 volociximab 65 Maxy G# 65 platform HDL Mimetic 65 Obatoclax 65 MKC# MKC# PP 65 pharmacogenomic translational research 65 oral anti arrhythmic 65 AS# amonafide L malate 65 Begins Dosing 65 markets Testim ® 65 HCV protease inhibitor 65 small molecule macrocyclic 65 commercializing oxidized glutathione 65 ARRY # 65 4 PDE4 enzyme 65 TNF Tumor Necrosis Factor 65 compound perifosine 65 UCB www.ucb group.com 65 HCV protease inhibitors 65 Ostarine ™ 65 sublingual tablet formulation 65 GW# [003] 65 PDE4 modulators 65 Submits NDA 65 lipid nanoparticle 65 HCV NS3 protease 65 Albugon 65 ocular formulation 65 Voreloxin 65 patented Aganocide compounds 65 sorafenib tablets small 65 kinesin spindle protein KSP 65 delta gamma agonist 65 Enrolls First 65 cetuximab Erbitux R 65 Rigel R# 65 Imatinib mesylate 65 Tumor necrosis factor 65 TLR9 agonist 65 memantine HCl 65 XP# XP# 65 TRANSDUR ™ 65 R Saizen R 65 diarrhea predominant irritable 65 commercialize SGN 65 HuCAL GOLD R 65 CEQ# 65 thalidomide Thalomid 65 ALTROPANE R 65 poly ADP ribose polymerase 65 Pentad TM 65 Tezampanel 65 inhibit oxidative stress 65 proprietary MSCRAMM ® 65 HuCAL PLATINUM ® CysDisplay 65 advanced metastatic renal 65 Anticalin R 65 receptors PPARs 65 selective serotonin 2C receptor 65 Fleximer 65 reformulates existing FDA 65 proprietary polysaccharide 65 class anticancer quinolone 65 Iluvien ® 65 aerosolized AAT 65 DEB# 65 NYSE PFE Exelon Rivastigmine 65 NEBIDO VANTAS SUPPRELIN LA 65 Submits Biologics License Application 65 essential thrombocythemia ET 65 Mg Uk 65 Piperacillin 65 visit www.genenews.com 65 provides adenoviral reagents 64 6R BH4 tetrahydrobiopterin naturally 64 ceftazidime 64 selectively binds 64 ESPRIT therapy 64 Trastuzumab DM1 64 Affilin ® 64 Safinamide 64 Kuvan sapropterin dihydrochloride 64 inhaled formulation 64 Aurora kinase inhibitor 64 RAF kinase 64 XOMA 3AB biodefense 64 candidate REP# 64 staphylococcal vaccines 64 selective antagonist 64 AN# topical anti 64 Micromet proprietary BiTE 64 factor TNF receptor 64 Zalypsis 64 PN# [001] 64 cladribine Cladribine Tablets 64 Granted Orphan Drug 64 Initiates Phase III 64 Myolimus 64 treat refractory angina 64 Aztreonam 64 UltiMAb TM 64 Receives Approvable Letter 64 apoptosis inducer 64 Medisorb ® 64 Cyclosert TM 64 Wafer polifeprosan 64 Paris IPN Euronext 64 Phase #b/#a clinical 64 long acting muscarinic 64 signal averaging electrocardiography 64 Peginterferon alfa 2b 64 OMP #R# 64 Aganocide TM 64 Nasdaq MNKD focused 64 DNA intercalator 64 thrombin component 64 Ovitrelle R Serostim 64 targeted alpha folate 64 protein receptors lectins 64 Fresenius Biotech 64 includes TOLAMBA TM 64 RH1 64 Vidaza R 64 Aptamer 64 TOCOSOL 64 Methylnaltrexone 64 nucleotide analogue 64 active AKT inhibitor 64 2hours #mins #.#secs M 64 PPI omeprazole 64 activin receptor type 64 drug monomethyl auristatin 64 imatinib Gleevec ® 64 LentiVector technology 64 gallium containing 64 gastro intestinal inflammation 64 Luteinizing Hormone Releasing Hormone 64 R roscovitine CDK cyclin 64 UltiMAb 64 Amigal TM 64 polymer conjugate technology 64 Retisert R 64 Glucagon Like Peptide 64 sunitinib Sutent ® 64 next generation URAT1 64 nitric oxide donating 64 FOLFOX6 chemotherapy regimen 64 stable nucleic acid 64 PF # [002] 64 Ceragenin ™ 64 antimitotic 64 Zolpimist ™ 64 Kit CD# positive 64 Enhanze Technology 64 markets HP Acthar 64 Pancreate 64 Submits Response 64 Tofacitinib 64 ProtAffin 64 MorphoSys proprietary 64 Receptor Agonist 64 Inc. Nasdaq OXGN 64 Endotis 64 chronic eosinophilic leukemia 64 inhibits Akt activation 64 DP VPA 64 vascular disrupting agents 64 Granulocyte Colony Stimulating Factor 64 candidate custirsen 64 synthetic ligand affinity 64 Aloprim TM allopurinol sodium 64 Payload TAP technology 64 Cannabinor 64 IgG1 monoclonal antibody 64 sanofi aventis Bayer Schering 64 RONDEL ™ 64 IMiDs 64 lead molecular radiotherapeutic 64 human IgG1 monoclonal 64 Pharmacokinetics PK 64 Boehringer Ingelheim MedImmune 64 Thiarabine 64 docetaxel Taxotere ® 64 Zoraxel TM 64 superparamagnetic iron oxide nanoparticles 64 Nasdaq AEGR 64 commercialize OncoGenex lead 64 investigational pharmacologically unique 64 TM Aganocide 64 interferon alpha IFN 64 Belimumab 64 MEDA AB publ 64 NovaDel oral spray 64 orally bioavailable 64 topical antifungal product 64 norepinephrine reuptake inhibitor 64 KL4 Surfactant 64 Hexvix ® 64 potent antiproliferative 64 including cyclosporine methotrexate 64 AEG# 64 ChromoCure develops 64 DNA methyltransferase inhibitors 64 ABLYNX 64 Recombinant Human 64 HIV protease inhibitor 64 drug conjugate 64 semi synthetic lipoglycopeptide 64 relapsed leukemia 64 mTOR mammalian target 64 Ecallantide 64 acyclovir Lauriad R 64 ® bortezomib 64 E CENP E 64 PDE# 64 Mipomersen 64 modified glutathione analog 64 RNA antagonists 64 Transdrug R 64 SGLT Inhibitors 64 Staphylococcus aureus Immune Globulin 64 Merck Serono Nycomed 64 INSPIRE Trial Phase III 64 vaccine GRNVAC1 64 Retisert ® 64 Earns Milestone Payment 64 monoclonal antibody MAb 64 omecamtiv mecarbil formerly 64 Cardium Therapeutics TM 64 PEGylated anti 64 XmAb TM 64 novel Cell Pouch 64 regarding Aethlon Medical 64 intravesical infusion therapy 64 MCSP respectively 64 tyrosine kinase inhibitor TKI 64 topically delivered 64 PEG irinotecan 64 daily injectable lipoglycopeptide 64 NOTE POSIDUR ™ 64 Anticalins R 64 Tyrosine Kinase Inhibitor 64 Licenses Novel 64 recombinant adeno associated 64 ispinesib SB # 64 advanced polymer conjugate 64 apoptosis inducers 64 cardiac muscle myosin 64 octreotide acetate 64 CK # novel 64 triciribine phosphate monohydrate 64 SGLT2 inhibitor 64 HCD# [002] 64 motexafin gadolinium Injection 64 myelofibrosis polycythemia vera 64 Oral NKTR 64 Combination REOLYSIN R 64 enhance ApoA 64 Modrenal R 64 utilizes InSite Vision 64 GlaxoSmithKline MedImmune 64 proprietary intranasal insulin 64 novel antiviral therapeutics 64 evaluating satraplatin 64 anti PlGF 64 Lovaza TM 64 oral isotype selective HDAC 64 JAK2 Inhibitor 64 anti CD3 64 naloxol derivative 64 Kuvan R 64 evaluating T DM1 64 Announce License Agreement 64 DiLA2 Platform 64 PROfusion 64 About Positron Positron 64 International LAB Pharma 64 forodesine purine nucleoside phosphorylase 64 selective androgen receptor modulators 64 SCIB1 64 inhibit VEGF 64 Aganocide 64 Vidaza ® 64 RNA antagonist 64 PDX pralatrexate 64 metformin sulfonylureas 64 palonosetron hydrochloride Injection Dacogen 64 Neulasta R 64 novel VDA molecule 64 CDK cyclin dependent 64 OctoPlus licensed 64 5 HT6 64 calcitonin gene related 64 RANK Ligand inhibitor 64 Angiolix R 64 anti atherothrombotic 64 anti secretory 64 Bosutinib 64 oxazolidinone 64 ® decitabine 64 RON Notch 64 rALLy clinical trial 64 engineered proteases 64 drug payload monomethyl 64 Company TAIFUN R 64 aldehyde dehydrogenase ALDH2 deficiency 64 Completes Enrollment 64 Vicriviroc 64 proprietary PEGylation 64 apricitabine ATC 63 novel therapeutic antibodies 63 Orally Active 63 diabetes irritable bowel 63 Personalized Immunotherapy 63 includes VIAtab TM 63 anti angiogenic agent 63 overactive bladder VANTAS R 63 Rectangular Column 63 Doripenem 63 humanised monoclonal antibody 63 Bavituximab 63 Receives Fast Track 63 cancer neuroendocrine tumor 63 Bruton tyrosine kinase 63 synthetic anti infective 63 SPP# aliskiren 63 SAR# [004] 63 delivers sumatriptan 63 anti miRs antisense oligonucleotide 63 Crucell NV NYSE Euronext 63 acadesine 63 adult multipotent stem 63 purified inactivated vaccine 63 JAK2 inhibitor 63 Humanized Anti 63 treat hyperphosphatemia 63 ® lenalidomide 63 SMaRT ™ 63 allogeneic cell 63 adecatumumab MT# 63 injectable investigational 63 Xeloda ® 63 subtype selective NMDA receptor 63 approved incretin mimetic 63 Reports Preclinical Data 63 NS#/#A protease 63 Systemic lupus erythematosus SLE 63 monoclonal antibody mAb 63 Letairis ambrisentan 63 Prodrug 63 Biolimus A9 63 Muraglitazar 63 prostanoid 63 Roche SWX ROG 63 HDAC Inhibitor 63 Glufosfamide 63 dasatinib Sprycel 63 Solazed TM 63 Anidulafungin 63 JAK1 63 coronary stent merged 63 novel tubulin binding 63 macrocyclic lactone 63 use transdermal sumatriptan 63 ALN PCS 63 Avian Transgenic Technology 63 ThermoDox ® clinical 63 specific lectin receptors 63 CD# monoclonal antibody 63 Custirsen 63 HuCAL antibody 63 rash pruritus nausea 63 gamma secretase inhibitor 63 dihydrochloride Tablets 63 paclitaxel Taxol ® 63 histone deacetylase HDAC 63 Polymerase Inhibitor 63 Prodarsan R 63 COLAZAL R 63 peptide peptide mimetic 63 radiation sensitizer 63 overactive bladder AA# 63 SinuNase ™ 63 Factor VIIa 63 Interferon gamma 63 influenza BCX# purine nucleoside 63 Potelligent TM Technology 63 HIV protease inhibitor Lexiva 63 NADiA R 63 angiogenesis inhibitor 63 Saizen R 63 TRAIL R2 63 prostate secretory 63 oral antiviral 63 developing Surfactant Replacement 63 HepeX B 63 HepDirect R 63 markets COLAZAL 63 thymidylate synthase TS 63 InterfeRx 63 TLR9 agonists 63 HQK 63 dependent kinase inhibitor 63 inhibitor COX 63 Resten NG 63 www.ucb group.com 63 Systemic Delivery 63 opioid receptor antagonist 63 BRAF kinase 63 MolecularBreeding 63 acting angiotensin 63 injectable formulation 63 Receive Milestone Payment 63 personalized cellular immunotherapy 63 ErbB3 HER3 63 Civacir TM Hepatitis C 63 var arrAnti = 63 Vaccine Adjuvant 63 broad spectrum cephalosporin 63 ALN HPN 63 Launches Generic Version 63 HuMax TF 63 Aviptadil 63 tumor xenograft models 63 Spiegelmer ® 63 evaluating tivozanib 63 MERREM 63 azelastine hydrochloride 63 #HT# 63 Kinesin Spindle Protein KSP 63 Indibulin ZIO 63 Ribavirin causes 63 non thiazolidinedione TZD 63 Ceflatonin R 63 Simulect 63 HCV protease 63 world safest multivalent 63 Sym# 63 Announces Poster Presentations 63 antibiotic candidate Ramoplanin 63 Phase Ib clinical trials 63 HIV integrase inhibitors 63 receptor modulators 63 catalytic antioxidant compounds 63 HER1 63 ABL inhibitor 63 Apoptone HE# 63 Copegus ® 63 Pain Neutralizer holds 63 lexidronam injection 63 Drug Candidate 63 Therapeutic Competitors companiesandmarkets.com adEgemonye 63 CIMZIA r 63 please visit http:/www.vandapharma.com 63 Dyax logo 63 treats acute lymphoblastic 63 vesicular monoamine transporter 63 HCV polymerase inhibitors 63 triggers apoptosis 63 Shigatoxin producing E. coli 63 IMA# 63 hyaluronidase enzyme 63 Takeda Kyowa Hakko Kirin 63 commercializing Loramyc ® 63 XL# XL# XL# 63 Adenoviral 63 NanoTab 63 Cephalon GlaxoSmithKline 63 compound ISA# 63 OMP #M# 63 tubulin binding 63 Albuferon albinterferon alfa 2b 63 B lymphocyte stimulator 63 bevacizumab Avastin R 63 microtubule inhibitor 63 MMAE 63 serine threonine kinase 63 HIV integrase inhibitor 63 ZK EPO 63 ThermoDox R 63 OXIGON TM 63 ATL# [002] 63 reslizumab 63 Guanilib 63 Lixivaptan 63 Submits IND 63 HepDirect prodrug 63 dihydrofolate reductase 63 Selective Electrochemical Tumor Ablation 63 Aganocide ® 63 Initiates Phase 63 histone deacetylase inhibitor 63 Locteron exclusively 63 selective adhesion molecule 63 neuronal nicotinic receptor NNR 63 ASONEP ™ 63 Adnectin 63 generation Hsp# inhibitor 63 5 HT4 agonist 63 phosphatidylserine PS targeting 63 Azacitidine 63 AQUA ® 63 novel DACH platinum 63 Nutra Pharma wholly owned 63 produces potent VLP 63 RhuDex ® 63 Elotuzumab 63 proprietary BiTE R 63 retaspimycin hydrochloride 63 interferon beta 1a infertility 63 nasal calcitonin product 63 www.ucb.com 63 Elesclomol 63 pathophysiological effects 63 receptor CXCR4 63 etanercept Enbrel 63 nilotinib Tasigna 63 protein mTOR 63 oligonucleotides Manoharan 63 Crucell genetically engineered 63 ELADUR ™ 63 sorafenib tablets 63 sapropterin dihydrochloride 63 ™ Lighting Savi 63 targeted diseased tissues 63 triple VEGF receptor 63 PGL# 63 CEL SCI Phase III 63 Peroxisome Proliferator Activated Receptor 63 GI GVHD common 63 selective estrogen receptor modulator 63 Gemzar gemcitabine 63 plasmid DNA pDNA 63 Oxytrex TM 63 HCl PEPCID ® famotidine 63 Company proprietary Biochronomer 63 psoriasis rheumatoid arthritis 63 MET RET 63 Nventa proprietary CoVal 63 Anti VEGF 63 Pegloticase 63 Seliciclib 63 COLAZAL ® 63 Small Modular SMIP 63 novel orally administered 63 Evoltra ® 63 synthetic siRNA 63 dihydrofolate reductase DHFR 63 investigational oral 63 COPEGUS R 63 Inc. Nasdaq MITI 63 echinocandin 63 nucleoside polymerase inhibitor 63 2A receptor agonist 63 AVAX AC Vaccine 63 particularly SANCTURA XR 63 dSLIM 63 non nucleoside 63 Aplidin 63 PER.C6 ® production 63 candidate oral AP# 63 potent cytotoxic 63 succinic 63 ALN TTR 63 subtype selective 63 D aspartate NMDA receptor 63 Solzira ™ 63 alvespimycin 63 kinase PI3K 63 PDE4 63 Solazed ™ 63 Fludara ®